References
- Bartkowski H M. Peritumoral edema. Progress in Experimental Tumor Research 1984; 27: 179–190
- Benitez P, Keisch M E, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. American Journal of Surgery 2007; 194: 456–462
- Bourke V A, Zhao D, Gilio J, Chang C H, Jiang L, Hahn E W, Mason R P. Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor. International Journal of Radiation Oncology, Biology, Physics 2007; 67: 1179–1186
- Chen B, Pogue B, Luna J, Hardman R, Hoopes P J, Hasan T. Tumor vascular permeabilization by vascular-targeting photosynthesization: effects, mechanism, and therapeutic implications. Clinical Cancer Research 2006; 12: 917–923
- Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D. Differentiation of prostate cancer from normal prostate tissue in an animal model: Conventional MRI and dynamic contrast-enhanced MRI, Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. 2005; 177: 935–939
- Hall E J, Giaccia A J. Radiobiology for the radiologist. Lippincott Williams & Wilkins, Philadelphia 2000
- Harms W, Peschke P, Weber K, Hensley F, Wolber G, Debus J, et al. Dose-dependent differential effects of low and pulsed dose-rate brachytherapy in a radioresistant syngenic rat prostate tumour model. International Journal of Radiation Biology 2002; 78: 617–623
- Ibbott G S, Hanson W F, O'Meara E, Kuske R R, Arthur D, Rabinovitch R, et al. Dose specification and quality assurance of radiation therapy oncology group protocol 95–17; a cooperative group study of iridium-192 breast implants as a sole therapy. International Journal of Radiation Oncology, Biology, Physics 2007; 69: 1572–1578
- Isaacs J T, Heston W D, Weissman R M, Coffey D S. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT. Cancer Research 1978; 38: 4353–4359
- Isaacs J, Yu G, Coffey D. The characterization of a newly identified, highly metastatic variety of the Dunning R 3327 rat prostatic adenocarcinoma system: The MatLyLu tumor. Investigative Urology 1981; 19: 20–24
- Johannsen M, Thiesen B, Gneveckow U, Taymoorian K, Waldöfner N, Scholz R, Deger S, Jung K, Loening S A, Jordan A. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate 2006; 66: 97–104
- Kal H, Struikmans H, Gebbink M, Voest E. Response of rat prostate and lung tumors to ionizing radiation combined with the angiogenesis inhibitor AMCA. Strahlentherapie und Onkologie 2004; 180: 798–804
- Kälkner K M, Wahlgren T, Ryberg M, Cohn-Cedermark G, Castellanos E, Zimmerman R, et al. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: A 6-year follow-up. Acta Oncologica 2007; 46: 909–917
- Kallmann R. Rodent tumor models in experimental cancer therapy. Pergamon Press, New York 1987
- Kazumoto T, Kato S, Tabushi K, Kutsutani-Nakamura Y, Mizuno H, Takahashi M, et al. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration. International Journal of Radiation Oncology, Biology, Physics 2007; 69: 1157–1166
- Kuske R R, Winter K, Arthur D W, Bolton J, Rabinovitch R, White J, et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95–17. International Journal of Radiation Oncology, Biology, Physics 2006; 65: 45–51
- Lohr F, Wentz F, Flentje M, Peschke P, Hahn E. Measurements of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327. Strahlentherapie und Onkologie 1993; 169: 438–445
- Persons C, Hermens A, Franken N, Wondergem J. Muscle wasting after radiotherapy in young and adult rats. Oncology Reports 2001; 8: 1117–1121
- Peschke P, Hahn E W, Wenz F, Lohr F, Braunschweig F, Wolber G, Zuna I, Wannenmacher M. Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia. Radiation Research 1998; 150: 423–430
- Rao B, Slotman B, Geldof A, Perez C. Radiation sensitivity of Copenhagen rat prostatic carcinoma (R3327-AT and R3327-MATLyLu). International Journal of Radiation Oncology, Biology, Physics 1991; 981–95
- Rivard M J, Coursey B M, DeWerd L A, Hanson W F, Huq M S, Ibbott G S, Mitch M G, Nath R, Williamson J F. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Medical Physics 2004; 31: 633–674
- Shikanov S, Shikanov A, Gofrit O, Nyska A, Corn B, Domb A J. Intratumoral delivery of paclitaxel for treatment of orthotopic prostate cancer. Journal of Pharmaceutical Sciences 2008; 98: 1005–1014
- Siemann D. Satisfactory and unsatisfactory tumor models: Factors influencing the selection of a tumor model for experimental evaluation. Rodent tumor models in experimental cancer therapy, R Kallmann. Pergamon Press, New York 1987; 12–15
- Skourou C, Hoopes P J, Strawbridge R, Paulsen K D. Feasibility studies of electrical impedance spectroscopy for early tumor detection in rats. Physiological Measurement 2004; 25: 335–346
- Skourou C, Rohr A, Hoopes P J, Paulsen K D. In vivo EIS characterization of tumour tissue properties is dominated by excess extracellular fluid. Physics in Medicine and Biology 2007; 52: 347–363
- Smolev J K, Heston W D, Scott W W, Coffey D S. Characterization of the Dunning R3327H prostatic adenocarcinoma: An appropriate animal model for prostatic cancer. Cancer Treatment Reports 1977; 61: 273–287
- Sun Myint A, Lee C D, Snee A J, Perkins K, Jelley F E, Wong H. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumors: The Clatterbridge experience. Clinical oncology (Royal College of Radiologists) 2007; 19: 711–719
- Tennant T, Kim H, Sokoloff M, Rinker-Schaeffer C. The Dunning model. The Prostate 2000; 43: 295–302
- Thorndyke C, Meeker B, Thomas G, Lakey W, McPhee M, Chapman J. The radiation sensitivities of R3327-H and R3327-AT rat prostate adenocarcinomas. Journal of Urology 1985; 134: 191–198
- Vuong T, Devic S, Podgorsak E. High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients with resectable cancer. Clinical Oncology 2007; 19: 701–705
- Zechmann C M, Woenne E C, Brix G, Radzwill N, Ilg M, Bachert P, Peschke P, Kirsch S, Kauczor H U, Delorme S, Semmler W, Kiessling F. Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors. Neoplasia 2007; 9: 57–67
- Zhou X, Chen B, Hoopes P J, Hasan T, Pogue B W. Tumor vascular area correlates with photosensitizer uptake: Analysis of verteporfin microvascular delivery in the Dunning rat prostate tumor. Photochemistry and Photobiology 2006; 82: 1348–1357